Betty A Hibler, MD in Clinton, IA - General Practice

Betty A Hibler, MD is a General Practice physician based in Clinton, Iowa. Betty A Hibler is licensed to practice in Iowa (license number 28317) and her current practice location is 1320 Main Ave, Clinton, Iowa. She can be reached at her office (for appointments etc.) via phone at (563) 243-3752.

NPI number for Betty A Hibler is 1235118837 and her current mailing address is 1320 Main Ave, Clinton, Iowa. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1235118837.

Contact Information

	Betty A Hibler, MD
	1320 Main Ave, Clinton, IA 52732-1923
	(563) 243-3752
	Not Available

Physician's Profile

Full Name	Betty A Hibler
Gender	Female
Speciality	General Practice
Location	1320 Main Ave, Clinton, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1235118837
Provider Enumeration Date: 01/11/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Betty A Hibler such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235118837	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	28317 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Betty A Hibler is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Betty A Hibler, MD 1320 Main Ave, Clinton, IA 52732-1923 Ph: (563) 243-3752	Betty A Hibler, MD 1320 Main Ave, Clinton, IA 52732-1923 Ph: (563) 243-3752

News Archive

New research disproves using anti-malaria drug for diabetes treatment

A drug used to treat malaria does not, after all, create new insulin-producing cells, according to a new paper from researchers at the University of California, Davis. The work, published in Cell Metabolism Nov. 2, refutes a study published in Cell in January.

Derma Sciences to raise $29M through private placement

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has entered into definitive agreements with select institutional investors to raise gross proceeds of approximately $29 million.

VA study examines use of medicinal maggots to heal diabetic foot ulcers

Maggot, or larval, therapy has been around since ancient times as a way to heal wounds. Now, the method has gone high-tech-in some ways-and it's being tested in a rigorous clinical trial at the Malcom Randall Veterans Affairs (VA) Medical Center in Gainesville, Fla. Recruitment is now underway.

Insight into merits and limitations of direct reprogramming strategies for cardiac regeneration

Direct reprogramming or Transdifferentiation is a way of inducing changes in the cell type from one lineage into another lineage, bypassing pluripotency.

Betty A Hibler, MD - General Practice in Clinton, IA